Company Snapshot
COMPANY INFORMATION
The Jenex Corporation
207-940 Sheldon Crt Burlington, ON L7L 5K6Tel:
(905)
632-3830Fax:
(905)
632-3774
Contact Name
John Aikman
Industry Health Care Distributors
Key Executives John Aikman, CEO
Holds rights to thermal therapy technology that provides topical relief to certain skin irritations resulting from insect bites and prevention of cold sores.
TOP INDUSTRY PLAYERS
(Links are to Snapshots.)
FINANCIAL RATIOS AS OF JUN 30/09
Listed
Close
52-wk High
52-wk Low
IAD
Latest Dividend
Yield
60-mo Beta
TSX-VEN/JEN (S)
$0.02
$0.05
$0.01
n.a.
n.a.
n.a.
n.a.
Avg 20-day Volume
P/E
12-mo EPS
EPS Date
1-yr Return
3-yr Return
5-yr Return
Market Cap. (000s)
n.a.
n.a.
$-0.03
Apr. 30/09
n.a.
n.a.
n.a.
$839
ANNUAL FINANCIALS
Periods ended:
12m July 31/08
12m July 31/07
12m July 31/06
$000s
$000s
$000s
Operating revenue
251
251
770
Net income
(2,103)
(1,608)
(1,835)
Total assets
138
799
978
$
$
$
Earnings per share*
(0.04)
(0.03)
(0.04)
* Common
COMPANY NEWS
Results for 'The Jenex Corporation' from past 30 days:
No hits.
(Links are to articles.)